Advertisement

N,N-Dimethyltryptamine: DMT-induced psychosis

      N,N-Dimethyltryptamine (DMT) is a novel hallucinogen that acts on brain serotonin receptors and produces a brief yet intense dream-like state with reported psycho-spiritual effects [
      • Hamill J.
      • Hallak J.
      • Dursun S.M.
      • Baker G.
      Ayahuasca: psychological and physiologic effects, pharmacology and potential uses in addiction and mental illness.
      ]. DMT is growing in popularity as a recreational substance but limited knowledge exists of its adverse effects [
      • Winstock A.R.
      • Kaar S.
      • Borschmann R.
      Dimethyltryptamine (DMT): prevalence, user characteristics and abuse liability in a large global sample.
      ]. We report the cases of two young male patients with no prior psychiatric history who presented to an urban academic emergency department (ED) with psychotic symptoms after consumption of DMT.

      Keywords

      To read this article in full you will need to make a payment
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Emergency Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Hamill J.
        • Hallak J.
        • Dursun S.M.
        • Baker G.
        Ayahuasca: psychological and physiologic effects, pharmacology and potential uses in addiction and mental illness.
        Curr Neuropharmacol. 2019; 17: 108-128
        • Winstock A.R.
        • Kaar S.
        • Borschmann R.
        Dimethyltryptamine (DMT): prevalence, user characteristics and abuse liability in a large global sample.
        J Psychopharmacol. 2014; 28: 49-54
        • Heise C.W.
        • Brooks D.E.
        Ayahuasca exposure: descriptive analysis of calls to US Poison Control Centers from 2005 to 2015.
        J Med Toxicol. 2017; 13: 245-248
        • Warren J.M.
        • Dham-Nayyar P.
        • Alexander J.
        Recreational use of naturally occurring dimethyltryptamine—contributing to psychosis?.
        Aust N Z J Psychiatry. 2013; 47: 398-399
        • Dos Santos R.G.
        • Bouso J.C.
        • Hallak J.E.C.
        Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies.
        Ther Adv Psychopharmacol. 2017; 7: 141-157